Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising EryKit, Syringe Kit, drugs, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Quince Therapeutics Inc.

Quince Therapeutics ( ($QNCX) ) has shared an update. On April 22, 2026, Quince Therapeutics increased the size of its board of directors to four m...

Quince Therapeutics Appoints June Bray to Board

These are the upcoming stock splits for the week of April 13 to April 17, based on TipRanks’ Stock Splits Calendar. A stock split is more of a visu...

Upcoming Stock Splits This Week (April 13-17, 2026) – Stay Invested

Quince Therapeutics ( ($QNCX) ) has shared an update. Quince Therapeutics, Inc. will implement a 1-for-10 reverse stock split of its common stock, ...

Quince Therapeutics Announces 1-for-10 Reverse Stock Split

Quince Therapeutics ( ($QNCX) ) has released a notification of late filing. Quince Therapeutics, Inc. has notified regulators that it will delay fi...

Quince Therapeutics Delays Annual 10-K Filing

Quince Therapeutics ( ($QNCX) ) has provided an update. On March 27, 2026, Quince Therapeutics paid approximately $5.5 million to the European Inve...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	QNCX	$1.36	0.00%	1.14M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	QNCX	$1.36	0%	1.14M
3
4
5
6

QNCX

QNCX

No Data Available

Get Quince Therapeutics Inc. Data in Excel

Get Quince Therapeutics Inc. Data in Excel